Stromal and vascular inputs into pancreatic cancer tumor neighborhoods
Stromal and vascular inputs into pancreatic cancer tumor neighborhoods
批准号:
10733718
负责人:
M. CELESTE SIMON
金额:
$66.43万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-15 至 2028-06-30
关键词:
AddressAngiogenesis InhibitorsB-LymphocytesBiologicalBlood VesselsCell divisionCellsChemoresistanceClinicalClinical TrialsDataData SetDesmoplasticDevelopmentEcosystemEndothelial CellsExhibitsFibroblastsGenetically Engineered MouseGeographyGoalsHeterogeneityHumanHypervascularHypoxiaImplantInvadedLipidsLymphaticMalignant NeoplasmsMalignant neoplasm of pancreasMetabolicMicroscopyModelingMolecularNeighborhoodsNutrientOxygenPancreatic Ductal AdenocarcinomaPathway interactionsProteinsSourceTechniquesTherapeuticUnsaturated Fatty AcidsVascular Endothelial CellVascular Endotheliumcancer cellclinically relevantcohortcopinghuman datahuman tissueimprovedinnovationinsightlipid metabolismmouse modelneoplastic cellpancreatic cancer cellspancreatic ductal adenocarcinoma cellpancreatic ductal adenocarcinoma modelpatient subsetsprecision medicineregional differenceresponsesupply chaintissue resourcetreatment strategytumortumor heterogeneitytumor microenvironment
中文摘要
项目总结
英文摘要
PROJECT SUMMARY
Cancer cells are the organizers of their surroundings and create a tumor microenvironment (TME) favoring cell
division even when oxygen and nutrients are limiting. An extreme example is pancreatic ductal adenocarcinoma
(PDAC) which establishes a metabolically hostile ecosystem characterized by a hypo-vascular, severely hypoxic,
and nutrient deprived stroma. Clinical trials targeting components of the PDAC stroma have not improved overall
survival in unselected cohorts. Thus, while opportunities for targeting the PDAC TME exist, the development of
anti-stromal therapies will require a better understanding of inter- and intra-tumoral heterogeneity.
Our labs have studied two features of the PDAC stroma: the vasculature and CAFs. By analyzing multiple human
datasets, and mouse models, we found that a significant portion of human PDACs (~10%) are hyper-vascular.
In murine models, hyper-vascularity is associated with increased sensitivity to angiogenesis inhibitors. In
addition, our preliminary studies have shown that in the more typical hypo-vascular tumors, hypoxia renders
PDAC tumor cells incapable of synthesizing unsaturated fatty acids (uFAs), and therefore critically dependent
upon lipids supplied by neighboring CAFs for their survival. Based on these data, we hypothesize that cancer-
associated micro-vasculature and lipid secreting fibroblasts represent under-exploited, clinically relevant targets
within the PDAC stroma.
Here, we propose an innovative approach to delineate the cellular mechanisms by which tumor cells build and
maintain critical metabolic “supply chains” and how regional differences within tumors influence nutrient
utilization and vascular intravasation. Our proposal addresses both basic and translational questions and utilizes
human tissue resources, implantable and genetically engineered mouse models, platforms to assess stromal
geography and metabolic features, and cancer-on-chip techniques for ex vivo modeling. Our ultimate goal is to
understand and manipulate the major sources from which PDAC cells derive essential nutrients (especially vital
uFAs) – focusing on micro-vessels and fibroblasts.
Aim 1. Determine the causes and consequences of vascular heterogeneity in PDAC
Aim 2. Delineate molecular mechanisms and therapeutic opportunities underlying stromal support of
lipid metabolism in PDAC
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIF-1alpha and FBP2 in sarcoma metabolism, progression, and metastasis
-
批准号:9263282
-
项目类别:
-
资助金额:$49.81万
-
财政年份:2017
-
负责人:M. CELESTE SIMON
-
依托单位:
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression
-
批准号:9975793
-
项目类别:
-
资助金额:$95.99万
-
财政年份:2017
-
负责人:M. CELESTE SIMON
-
依托单位:
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression
-
批准号:9390182
-
项目类别:
-
资助金额:$89.94万
-
财政年份:2017
-
负责人:M. CELESTE SIMON
-
依托单位:
Metabolic Influences on Complex Tumor Neighborhoods
-
批准号:10737396
-
项目类别:
-
资助金额:$92.5万
-
财政年份:2017
-
负责人:M. CELESTE SIMON
-
依托单位:
HIF-1alpha and FBP2 in sarcoma metabolism, progression, and metastasis
-
批准号:10059906
-
项目类别:
-
资助金额:$7.54万
-
财政年份:2017
-
负责人:M. CELESTE SIMON
-
依托单位:
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression
-
批准号:10214558
-
项目类别:
-
资助金额:$95.99万
-
财政年份:2017
-
负责人:M. CELESTE SIMON
-
依托单位:
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease Progression
-
批准号:10456722
-
项目类别:
-
资助金额:$94.07万
-
财政年份:2017
-
负责人:M. CELESTE SIMON
-
依托单位:
HIF-1alpha and FBP2 in sarcoma metabolism, progression, and metastasis
-
批准号:10080711
-
项目类别:
-
资助金额:$53.27万
-
财政年份:2017
-
负责人:M. CELESTE SIMON
-
依托单位:
HIFs and VEGF in sarcoma progression, metastasis, and radiation response
-
批准号:8332256
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2011
-
负责人:M. CELESTE SIMON
-
依托单位:
HIFs and VEGF in sarcoma progression, metastasis, and radiation response
-
批准号:8727484
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2011
-
负责人:M. CELESTE SIMON
-
依托单位:
HIFs and VEGF in sarcoma progression, metastasis, and radiation response
-
批准号:8514541
-
项目类别:
-
资助金额:$31.21万
-
财政年份:2011
-
负责人:M. CELESTE SIMON
-
依托单位:
HIFs and VEGF in sarcoma progression, metastasis, and radiation response
-
批准号:8889049
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2011
-
负责人:M. CELESTE SIMON
-
依托单位:
HIFs and VEGF in sarcoma progression, metastasis, and radiation response
-
批准号:8086285
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2011
-
负责人:M. CELESTE SIMON
-
依托单位:
The role of HIF-1a in Skin Biology
-
批准号:7678122
-
项目类别:
-
资助金额:$6.86万
-
财政年份:2009
-
负责人:M. CELESTE SIMON
-
依托单位:
Hypoxia and Development, Physiology and Disease
-
批准号:7000961
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2005
-
负责人:M. CELESTE SIMON
-
依托单位:
Administrative Core
-
批准号:8327683
-
项目类别:
-
资助金额:$7.98万
-
财政年份:2004
-
负责人:M. CELESTE SIMON
-
依托单位:
Administrative Core
-
批准号:8382060
-
项目类别:
-
资助金额:$7.99万
-
财政年份:2004
-
负责人:M. CELESTE SIMON
-
依托单位:
Cancer cell adaptation to metabolic stress
-
批准号:7937714
-
项目类别:
-
资助金额:$123.03万
-
财政年份:2004
-
负责人:M. CELESTE SIMON
-
依托单位:
Metabolic Outcomes of c-MYC, p53 and mTOR Regulation by HIF
-
批准号:8135230
-
项目类别:
-
资助金额:$27.34万
-
财政年份:2004
-
负责人:M. CELESTE SIMON
-
依托单位:
Cancer cell adaptation to metabolic stress
-
批准号:8928567
-
项目类别:
-
资助金额:$115.96万
-
财政年份:2004
-
负责人:M. CELESTE SIMON
-
依托单位:
海外基金